Health Care · Biologics & Biosimilars
ONL Therapeutics: Risk & public record
ONL Therapeutics: 6 research papers in five years.
Data updated Nov 20, 2026 · Back to the company report
What the registers and the postings say about this employer.
Legal entity active
ONL Therapeutics, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Public record
ONL Therapeutics: 6 research papers in five years.
Research outputpapers its people wrote, per OpenAlex
6papers in five years
215citations
Retinal Diseases and Treatments
Medicine
8 papers
Retinal Development and Disorders
Medicine
7 papers
Glaucoma and retinal disorders
Medicine
3 papers
Cell death mechanisms and regulation
Biochemistry, Genetics and Molecular Biology
3 papers
Ocular Diseases and Behçet’s Syndrome
Medicine
3 papers
Patents
Published US applications
2
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.
